Gene-Editing Treatment Cuts Swelling Attacks by 87% in Trial

A one-time gene-editing treatment just became the first to succeed in a major clinical trial, reducing dangerous swelling attacks by 87% for people with a rare genetic condition.

The breakthrough could change what's possible for treating genetic diseases.